Royal Philips announces that it has acquired Remote Diagnostic Technologies (RDT), a UK-based provider of pre-hospital technologies for monitoring, cardiac therapy, and data management—a move, officials say, that will strengthen Philips’ position in the resuscitation and emergency care market. Financial details of the transaction were not disclosed.
Philips already offers a range of monitoring and therapeutic technologies, such as automated external defibrillators, advanced life support monitors, and data management solutions. RDT will complement this with a product range for ambulance and emergency responders, which includes Tempus ALS, a modularized monitor and defibrillator that offers premium functionality in a smaller, lighter and more flexible package, company officials say. RDT also offers monitors equipped with telecommunication capabilities for various emergency responders.
“We are committed to investing in and expanding our resuscitation and emergency care offering, and with the acquisition of RDT we can boost our capabilities and portfolio in this vital area of healthcare,” says Arman Voskerchyan, business leader for therapeutic care at Philips. “With its focus on the pre-hospital market, RDT’s portfolio of emergency care solutions will enable Philips to grow its presence in this market, as we further build our health technology portfolio and extend the range of connected, data-driven solutions we offer to our customers.”
Graham Murphy, CEO of RDT, also spoke out about the deal, commenting: “We are delighted to become part of Philips and continue on our journey that began over 20 years ago. Our mission is very much aligned with Philips’ own, as we are committed to transforming the delivery of care and improving patient outcomes driven by customer-focused innovation. Together, we will continue to enable prehospital caregivers to make a real difference to patient outcomes everywhere.”
RDT was founded in 1997 and employs approximately 100 employees. The company is headquartered in Hampshire, U.K., with activities in Europe and North America. Within the Therapeutic Care business group, RDT will be a business alongside the existing Emergency Care & Resuscitation and Hospital Respiratory Care businesses.